Author details

Full Name

Benjamin TrinitÃ©

Affiliation

ORCID

Career Start Year

2000

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36853940	Cyanovirin-N binds to select SARS-CoV-2 spike oligosaccharides outside of the receptor binding domain and blocks infection by SARS-CoV-2.	Proc Natl Acad Sci U S A	2023
37775521	Safety and immunogenicity of a recombinant protein RBD fusion heterodimer vaccine against SARS-CoV-2.	NPJ Vaccines	2023
37024469	An engineered HIV-1 Gag-based VLP displaying high antigen density induces strong antibody-dependent functional immune responses.	NPJ Vaccines	2023
36495129	Impact of chemotherapy and/or immunotherapy on neutralizing antibody response to SARS-CoV-2 mRNA-1237 vaccine in patients with solid tumors.	Mol Oncol	2023
37131861	Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial.	Lancet Reg Health Eur	2023
36748086	Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2.	iScience	2023
36999095	Impact of hybrid immunity booster vaccination and Omicron breakthrough infection on SARS-CoV-2 VOCs cross-neutralization.	iScience	2023
37240371	Exploring FeLV-Gag-Based VLPs as a New Vaccine Platform-Analysis of Production and Immunogenicity.	Int J Mol Sci	2023
34693968	Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Hyperimmune Immunoglobulin Demonstrates Potent Neutralization and Antibody-Dependent Cellular Cytotoxicity and Phagocytosis Through N and S Proteins.	J Infect Dis	2022
35595256	Reduced humoral response 3 months following BNT162b2 vaccination in SARS-CoV-2 uninfected residents of long-term care facilities.	Age Ageing	2022
36042275	Glucocorticoids' treatment impairs the medium-term immunogenic response to SARS-CoV-2 mRNA vaccines in Systemic Lupus Erythematosus patients.	Sci Rep	2022
36167932	Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and humoral responses against different variants of concern in domestic pet animals and stray cats from North-Eastern Spain.	Transbound Emerg Dis	2022
35961779	Efficacy of SARS-CoV-2 vaccination in patients with monoclonal gammopathies: A cross sectional study.	Life Sci Alliance	2022
35821254	Author Correction to: SARS-CoV-2 interaction with Siglec-1 mediates trans-infection by dendritic cells.	Cell Mol Immunol	2022
35572570	Virological and Clinical Determinants of the Magnitude of Humoral Responses to SARS-CoV-2 in Mild-Symptomatic Individuals.	Front Immunol	2022
36320330	Kinetics of immune responses elicited after three mRNA COVID-19 vaccine doses in predominantly antibody-deficient individuals.	iScience	2022
35602059	Heterogeneous Infectivity and Pathogenesis of SARS-CoV-2 Variants Beta, Delta and Omicron in Transgenic K18-hACE2 and Wildtype Mice.	Front Microbiol	2022
35233547	Clinical course impacts early kinetics,magnitude, and amplitude of SARS-CoV-2 neutralizing antibodies beyond 1 year after infection.	Cell Rep Med	2022
35025963	Evaluation of SARS-CoV-2 entry, inflammation and new therapeutics in human lung tissue cells.	PLoS Pathogens	2022
34362897	Seven-month kinetics of SARS-CoV-2 antibodies and role of pre-existing antibodies to human coronaviruses.	Nature Communications	2021
34282982	Mouthwashes with CPC Reduce the Infectivity of SARS-CoV-2 Variants In Vitro.	J Dent Res	2021
33510275	SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity.	Sci Rep	2021
33554155	Stable neutralizing antibody levels 6Â months after mild and severe COVID-19 episodes.	Med	2021
34337095	Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.	Open Forum Infect Dis	2021
33816475	An Esrrb and Nanog Cell Fate Regulatory Module Controlled by Feed Forward Loop Interactions.	Front Cell Dev Biol	2021
34782760	SARS-CoV-2 interaction with Siglec-1 mediates trans-infection by dendritic cells.	Cell Mol Immunol	2021
34960795	First Detection of SARS-CoV-2 Delta (B.1.617.2) Variant of Concern in a Dog with Clinical Signs in Spain.	Viruses	2021
32273392	PSGL-1 restricts HIV-1 infectivity by blocking virus particle attachment to target cells.	Proceedings of the National Academy of Sciences of the United States of America	2020
31242909	NNRTI-induced HIV-1 protease-mediated cytotoxicity induces rapid death of CD4 T cells during productive infection and latency reversal.	Retrovirology	2019
30662943	Cofilin hyperactivation in HIV infection and targeting the cofilin pathway using an anti-Î±<sub>4</sub>Î²<sub>7</sub> integrin antibody.	Sci Adv	2019
28652233	Potent Inhibition of HIV-1 Replication in Resting CD4 T Cells by Resveratrol and Pterostilbene.	Antimicrob Agents Chemother	2017
27466246	Erratum for TrinitÃ© et al., HIV-1 Vpr- and Reverse Transcription-Induced Apoptosis in Resting Peripheral Blood CD4 T Cells and Protection by Common Gamma-Chain Cytokines.	J Virol	2016
26728316	HIV-1 latency and virus production from unintegrated genomes following direct infection of resting CD4 T cells.	Retrovirology	2016
26537673	HIV-1 Vpr- and Reverse Transcription-Induced Apoptosis in Resting Peripheral Blood CD4 T Cells and Protection by Common Gamma-Chain Cytokines.	J Virol	2015
26537682	A Subset of CD4/CD8 Double-Negative T Cells Expresses HIV Proteins in Patients on Antiretroviral Therapy.	J Virol	2015
25187551	On the laws of virus spread through cell populations.	J Virol	2014
25330112	Suppression of Foxo1 activity and down-modulation of CD62L (L-selectin) in HIV-1 infected resting CD4 T cells.	PLoS One	2014
25313645	Induced expression of nucleolin phosphorylation-deficient mutant confers dominant-negative effect on cell proliferation.	PLoS ONE	2014
23269844	Relative contribution of free-virus and synaptic transmission to the spread of HIV-1 through target cell populations.	Biology Letters	2013
24049167	An HIV-1 replication pathway utilizing reverse transcription products that fail to integrate.	J Virol	2013
19010918	Killer dendritic cells link innate and adaptive immunity against established osteosarcoma in rats.	Cancer Res	2008
15643985	Prolongation of heart allograft survival by immature dendritic cells generated from recipient type bone marrow progenitors.	American Journal of Transplantation	2005
16081812	Immature CD4- CD103+ rat dendritic cells induce rapid caspase-independent apoptosis-like cell death in various tumor and nontumor cells and phagocytose their victims.	Journal of Immunology	2005
15021837	Presentation of donor major histocompatibility complex class II antigens by dna vaccination prolongs heart allograft survival.	Transplantation	2004
12193693	Two phenotypically distinct subsets of spleen dendritic cells in rats exhibit different cytokine production and T cell stimulatory activity.	Journal of Immunology	2002
11035052	A subset of cytolytic dendritic cells in rat.	Journal of Immunology	2000